ScripPost-hoc analyses of data sets from Phase III clinical trials that failed to meet primary endpoints might look like grasping at straws but in orphan indications there maybe some justification. Executi
ScripCytokinetics' Tirasemtiv Thanks to funding from the ALS Association's Ice Bucket Challenge and a partnership with Astellas Pharma Inc. , Cytokinetics Inc. pursued Phase III development of its f
ScripEli Lilly & Co. 's chief financial officer (CFO) Derica Rice will be retiring at the end of this year after being at the company for 27 years. Rice was previously Lilly's executive vice president
ScripCEO Toby Wilson Waterworth outlines Atlantic Healthcare PLC 's development and filing plans for lead product, alicaforsen, for the treatment of pouchitis – a condition for which there are currently